Israeli Start-Up Alcobra Develops New Treatment for Attention Deficit Disorder

December 2, 2013 3:26 pm 2 comments
Israel's Alcobra Pharmaceuticals has a new non-stimulant treatment for ADHD.

Israel's Alcobra Pharmaceuticals has a new non-stimulant treatment for ADHD.

Israeli pharmaceutical start-up Alcobra Pharmaceuticals is listed on the NASDAQ electronic stock exchange under the ticker ADHD, the disease it treats with a non-stimulant compound that is expected to come to the market in 2015.

In an interview with Israeli business daily Globes, CEO Dr. Yaron Daniely explained how the company was originally created in 2008 to develop the molecule metadoxine to help inhibit the effects of alcohol on the brain.

“The goal was to create a pill that would quickly reduce blood alcohol levels, so that people would be able to drive safely,” explains Daniely. “It turned out the drug had no significant impact on removing alcohol from the blood, but it had a very significant impact on cognitive ability. In driving, memory, and attention tests that were conducted, it was as though those people were not drunk, despite the fact that, in terms of the amount of alcohol in their blood, it was not clear that they would be able to stand on their own two feet. So the idea to treat Attention Deficit Disorder came about.”

A pilot the company conducted in 2010 among 40 adults with ADHD showed “an immediate and significant improvement in attention tests. As a result of this, the company reinvented itself,” Daniely said, which is when he was named by researchers Dr. Dalia Megiddo and Udi Gilboa to be its new CEO.

Bilingual with a Ph.D. from the Sackler Institute of Graduate Biomedical Sciences at the New York University School of Medicine, an NIH Visiting Fellow in Cell Biology, a Postdoctoral Fellow in the Department of Molecular Cell Biology at The Weizmann Institute for Science, in Rehovot, and an MBA from the Technion – Israel Institute of Technology, Daniely also was VP Business Development at Gamida Cell Ltd., managing its joint venture with Teva Pharmaceutical Industries Ltd.(NYSE: TEVA; TASE: TEVA) to develop a cancer drug.

The idea was to approach TEVA to fund the start-up, which it did with $5 million to fund its first tests. But with TEVA later in a management crisis, and its options to increase its position in Alcobra expired, the team sought an IPO on the NASDAQ, which has since net it some $60 million in proceeds and a market capitalization of $220 million, more than enough to fund its final tests and market launch.

Daniely said the chemical compound metadoxine has been approved for 40 years for the treatment of liver disease in third-world countries, including India, China, Russia, and Thailand. The company has registered a patent for the use of metadoxine for neurological conditions, through a timed-release of the substance, so its effect on the patient lasts a few hours.

Globes said that Alcobra has no labs, its raw materials are manufactured by a third party in Germany, and the pills themselves are manufactured in the US. The company believes that the drug combines the benefits of the two existing classes of ADHD drugs – the stimulants, such as Ritalin and Concerta, and the non-stimulant drugs, such as Strattera – and claims that it does not have their drawbacks.

According to the company, the results of the clinical trials showed that the drug is not addictive, worked faster and was twice as effective as the existing non-stimulant drugs, and had a similar anti-ADHD effect to that of the stimulants. It primarily affects cognitive ability, less so hyperactivity.

Daniely advised other Israeli start-ups to follow four lessons from Alcobra’s successful IPO. “The first element was quality, and a refusal to compromise,” he said. “Alcobra, from day one, tried to be different from other companies. We have an almost pedantic stubbornness not to do things too small or too short, but rather to do the things the way we would if we were a company in Silicon Valley. Therefore, our Phase II trial didn’t include 20 people over two weeks, instead, it included 120 people, with a placebo control, over the course of six weeks, using the exact same measures that all the ADHD drugs in the world are measured by. Many companies understand too late that they are conducting poorer trials without the appropriate controls.”

The second element was the company’s target market. “There’s nothing like ADHD,” he says. “First of all, people understand the market; there are drugs, it is known how much each company is selling and why, there are patients, there is a market that turns over $4 billion each year in the US. Also, people think they understand what ADHD is. It affects almost everyone, their kid, or their nephew.”

A third element is the pace of development: “With ADHD, unlike rare cancers, participants for clinical trials are incredibly easy to find. So our time to market and our ability to build our development process are such that almost every month we have good news for shareholders. The phase III trial will include 300 patients, in 20 medical centers, over the course of six months.”

The fourth element that helped secure funding was his native-English speaking ability, personal CV and track record and a decision to invite well-known professionals from the ADHD research community to be on their team, in this case, Prof. Lenard Adler, a researcher from NYU and an expert in ADHD drug development, who serves as head of the clinical committee that advises the company. “When someone like him sits next to you and says: ‘I conducted the trial and I stand behind the results,’ they can’t blow you off. Israeli entrepreneurs need to understand this and bring these people to their companies, so they can bridge the gap,” Daniely said.

While the company tried to get funding in Israel, where ADHD is less frequently diagnosed, its success in raising money on the NASDAQ has led many other young pharma companies to its doors, seeking advice. Its success has also led to new projects.

“Many things happened at the company, and our ability to implement plans grew. We had a tremendous opportunity to treat fragile X syndrome, which is associated with autism. It is a very common condition, which is very difficult for many who suffer from it, and there is no treatment. In a trial we conducted on animals with a kind of fragile X, we came up with outstanding results. It completely normalized learning, memory, social behavior, and communication. In parallel, the market in the US was still on fire, and said, ‘go, secure the investment, and bring in more cash,’” Daniely said.

The funds Alcobra raised guarantee that the company will have full funding until it is approved as a drug for adult ADHD, which, according to Daniely, is expected to reach market in late 2015, and for children soon afterwards. The money will also fund the fragile X trial.

2 Comments

  • In this period of financial crisis, you usually do not have to spend huge amount of money just to find out girls
    get their clothes off in front individuals. You have to discover once the nude models from the sex chat website can be extremely beautiful and
    deliciously attractive. Military husbands stationed in the Middle
    East have been in a position to witness the birth of an youngster through webcams.

  • Davida Rosenberg

    Please update me when this will be available in the U.S.
    A family member age 36 male.. has suffered his whole young life with this condition.

Leave a Reply

Please note: comments may be published in the Algemeiner print edition.


Current day month ye@r *

More...

  • Music US & Canada Lady Gaga Accepts ADL Award: ‘Your Philosophies Are So in Line With Ours’ (VIDEO)

    Lady Gaga Accepts ADL Award: ‘Your Philosophies Are So in Line With Ours’ (VIDEO)

    Pop superstar Lady Gaga on Thursday accepted an award from Jewish human rights group the Anti-Defamation League (ADL) on behalf of her Born This Way Foundation, which strives to combat bullying among young people. “Your philosophies are so in line with ours,” she said of the ADL upon accepting the Making a Difference Award in a videotaped message, which was shown at a ceremony in New York City. “We want to help young people know that their feelings and who they are on [...]

    Read more →
  • Music Personalities At 80, Singer-Songwriter Leonard Cohen’s Jewish Roots ‘Very Much Intact’

    At 80, Singer-Songwriter Leonard Cohen’s Jewish Roots ‘Very Much Intact’

    JNS.org – Eighty years young, Leonard Cohen fits many descriptions—singer, songwriter, poet, novelist, monk. From his Jewish upbringing in Canada to the present day, Cohen has always explored his spiritual side. This month, the singer-songwriter released the CD (May 12) and iTunes (on May 8 of this year) formats of his latest album, Can’t Forget: A Souvenir of the Grand Tour, which features live recordings from his world tours in 2012 and 2013. Last year, Cohen’s Popular Problems was voted by Rolling Stone [...]

    Read more →
  • Europe Sports FIFA Head Says Israel Should Not be Booted From World Soccer Association

    FIFA Head Says Israel Should Not be Booted From World Soccer Association

    JNS.org – Fédération Internationale de Football Association (FIFA) head Sepp Blatter said during a meeting with Israeli Prime Minister Benjamin Netanyahu that contrary to Palestinian complaints, Israel has not violated any FIFA statutes and should not be suspended from international soccer’s governing body. “We should not come to one federation saying we will exclude them,” said Blatter, the Jerusalem Post reported. “If the national association is fulfilling its obligations then there is no need to intervene,” he said. “I’m on a [...]

    Read more →
  • Featured Middle East Sports Jewish Rights Group Slams Palestinian Attempts to Suspend Israel From FIFA

    Jewish Rights Group Slams Palestinian Attempts to Suspend Israel From FIFA

    Jewish human rights group the Simon Wiesenthal Center (SWC) said on Tuesday it was “appalled” by a Palestinian Football Association initiative to suspend Israel from FIFA, calling it another “front waged in the context of the Palestinian Boycott, Divestment, Sanctions (BDS) campaign.” “We are appalled at the temerity of the Palestinan Football Association (PFA) demand that FIFA suspend Israel at your forthcoming Congress in Zurich,” wrote the group’s international relations director, Dr. Shimon Samuels, in a letter to FIFA President Joseph [...]

    Read more →
  • Theater US & Canada Star of Auschwitz Thriller Says ‘God Was Holding the Hand of Every Jew in the Gas Chamber’ (VIDEO)

    Star of Auschwitz Thriller Says ‘God Was Holding the Hand of Every Jew in the Gas Chamber’ (VIDEO)

    The lead actor in Son of Saul, an Auschwitz thriller featured at this year’s Cannes Film Festival, told the UK’s The Guardian that he believes God was “holding the hand” of each Jew who died in the Nazi gas chambers during the Holocaust. “I do not for one nanosecond like to pretend that God is off the hook. He could and should have stopped it at a much earlier stage,” Géza Röhrig, 48, said. ”But I would not be able to get [...]

    Read more →
  • Music Backstreet Boys Singer Howie D Gushes Over Masada During Israel Trip

    Backstreet Boys Singer Howie D Gushes Over Masada During Israel Trip

    Backstreet Boys singer Howie Dorough took to Instagram on Tuesday to marvel about climbing the famed Masada fortress with his band during their visit to Israel, where they will perform this week for the first time. The group’s second day of sightseeing in the Jewish state included the Masada hike, and taking a mud bath at the Dead Sea. A picture from the band’s official Twitter page shows the five singers covered in mud. While relaxing in the Dead Sea, [...]

    Read more →
  • Book Reviews US & Canada ‘Arms and the Dudes:’ New Book, Film Detail How Ex-Orthodox Yeshiva Guys Became Top Suppliers for Afghan Army

    ‘Arms and the Dudes:’ New Book, Film Detail How Ex-Orthodox Yeshiva Guys Became Top Suppliers for Afghan Army

    A new book and its upcoming film adaptation tell the true story of how three former yeshiva students who habitually smoked marijuana scored a $300 million contract from the U.S. government to supply weapons for the Afghan Army, the New York Daily News reported on Sunday. Arms and the Dudes details how the Miami Beach potheads became “the most unlikely gunrunners in history,” according to the book’s author, investigative reporter Guy Lawson. The tale begins with Efraim Diveroli, nephew of [...]

    Read more →
  • Blogs Theater Natalie Portman: Israel-Themed ‘A Tale of Love and Darkness’ Not Political

    Natalie Portman: Israel-Themed ‘A Tale of Love and Darkness’ Not Political

    JNS.org – Natalie Portman, who directs and stars in the new Hebrew-language film adaptation of author Amos Oz’s A Tale of Love and Darkness, says that despite Oz’s record as a vocal left-wing critic of Israel, her film is not political. Like the book on which it is based, Portman’s film is about a young boy at the time of the founding of the state of Israel. “I think the movie is very much about this very particular, specific family story. Of [...]

    Read more →



Sign up now to receive our regular news briefs.